Overview of Chemotherapy Devices MarketThe Global Chemotherapy Devices Market is valued at USD 0.21 Billion in 2024 and is ...

DSCI has been designated the nodal training centre under the Prime Minister's DCCC initiative. "This initiative aims to ...

A new review published in the Journal of the American Medical Association (JAMA) reports that early-onset gastrointestinal cancers—including colon, pancreatic, and stomach cancers—are rising ...

A Pinellas County businessman accused of orchestrating a massive fraud scheme appeared in federal court on Thursday afternoon ...

The rate of COVID-related intensive care unit (ICU) admissions was 9.2 per 1,000 person-years among patients who received a ...

Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

The Trump administration wants to boost Medicare payments for hospital outpatient services by $8.1 billion next year — while ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

McLaughlin claimed that the family entered the United States illegally and that “Any implications that ICE would deny a child ...

I N 1971 RICHARD NIXON, then America’s president, announced a “war on cancer”. Just two years earlier the Apollo programme ...

Cancer patients who receive COVID boosters are far less likely to be hospitalized, but vaccination rates remain alarmingly ...

The FDA has accepted the supplemental new drug application for decitabine/cedazuridine plus venetoclax to treat adults with AML.